https://www.statcounter.com/counter/counter.js
Web Analytics
Home » Posts tagged with » pharma acquisition news
Jazz Pharmaceuticals acquires Cavion, developer of essential tremor drugs

Jazz Pharmaceuticals acquires Cavion, developer of essential tremor drugs

Jazz Pharmaceuticals acquisition of Cavion : Irish pharma company Jazz Pharmaceuticals has acquired US-based clinical-stage pharma company Cavion, a developer of essential tremor drugs, in a deal worth up to $312.5 million as per the latest pharma acquisition news. Based in Cambridge, Massachusetts, Cavion is engaged in developing therapies aimed at regulating the T-type calcium […]

Neoleukin completes merger with Aquinox Pharmaceuticals

US biopharma company Neoleukin Therapeutics has wrapped up a previously announced merger with Canadian pharma company Aquinox Pharmaceuticals. Headquartered in Vancouver, Aquinox Pharmaceuticals focused on discovering and developing novel therapeutics for conditions related to inflammation, inflammatory pain, and blood cancers. On the other hand, Neoleukin creates next-generation immunotherapies by using its de novo protein design […]

Continue reading …
NKF to invest $95m in US generic injectables company Meitheal

Pharma acquisition news : Hong Kong King-Friend Industrial Company, a subsidiary of Chinese manufacturer Nanjing King-Friend Biochemical Pharmaceutical Company (NKF), has agreed to increase its stake in US generic injectables company Meitheal Pharmaceuticals for $95 million. Following the completion of the transaction, which is likely to be in Q4 2019, NKF will have a majority stake […]

Continue reading …
Bayer to fully acquire US cell therapy company BlueRock Therapeutics

Bayer acquisition of BlueRock Therapeutics : Bayer will take full ownership in US cell therapy company BlueRock Therapeutics for an enterprise value of up to $1 billion, as per the latest pharma acquisition news. Headquartered in Cambridge, BlueRock Therapeutics develops engineered cell therapies in the fields of neurology, cardiology, and immunology using its proprietary induced […]

Continue reading …
Permira Funds to acquire US CDMO Cambrex for $2.4bn

Permira acquisition of Cambrex : Global investment firm Permira Funds, through one of its affiliates, has agreed to acquire US contract development and manufacturing organization (US CDMO) Cambrex for about $2.4 billion, including the assumption of its net debt. Based in New Jersey, Cambrex is a small molecule company that offers drug substance, drug product, and […]

Continue reading …
Mylan Upjohn merger : Pfizer to merge off-patent drugs unit with Mylan

Mylan Upjohn merger : US pharma giant Pfizer will spin off Upjohn, its off-patent branded and generic established medicines business, and merge it with Dutch pharma company Mylan, to form a new global pharma company. As per the terms of the all-stock, Reverse Morris Trust transaction, each of Mylan shares will be converted into one […]

Continue reading …
Italian pharma company Zambon acquires Breath Therapeutics for €140m

Zambon acquisition of Breath Therapeutics : Italian pharma company Zambon has acquired German biopharma company Breath Therapeutics and its subsidiaries for €140 million, which can potentially go up to total €500 million based on the latter’s achievement of certain regulatory and sales milestones. Breath Therapeutics, which is based in Munich as well as Menlo Park […]

Continue reading …
Ligand acquires antigen-discovery company Ab Initio Biotherapeutics

Ligand acquisition of Ab Initio : US biopharma company Ligand Pharmaceuticals has acquired California-based antigen-discovery company Ab Initio Biotherapeutics for $12 million in an all-cash deal, as per the latest pharma acquisition news. According to Ligand Pharmaceuticals, design and preparation of antigen are the first steps required for discovering therapeutic antibodies. The US biopharma company […]

Continue reading …
AbbVie to acquire Botox developer Allergan for $63bn

AbbVie acquisition of Allergan : US biopharma company AbbVie is all set to acquire Botox developer Allergan, an Irish pharma company, for $63 billion in a cash cum stock deal, as per pharma acquisition news. Headquartered in Chicago, AbbVie is engaged in developing drugs in areas such as immunology, oncology, neuroscience, and virology. On the […]

Continue reading …
PureTech Health acquires LYT-100 for lymphedema treatment

US biopharma company PureTech Health has acquired a clinical-stage product candidate called LYT-100, which will be developed as the potential treatment of lymphedema, and other lymphatic and immunofibrotic diseases, as per the latest pharma acquisition news. The seller of LYT-100 and the financial terms of the acquisition were not disclosed by PureTech Health. The drug […]

Continue reading …
Page 1 of 212